EPCA or early prostate cancer antigen, can successfully detect prostate cancer in its earliest stages.
Ads by Google
Prostate Cancer Treatment and Symptoms
Discovery May Pave Way for Immunotherapy Treatments for Prostate Cancer.
Prostate testing rates need to increase dramatically to save the 30,000 men who die each year from prostate cancer.
Prostate cancer continues to increase its death grip on African American men as about 1,000 black men are expected to die this year from the disease.
A pilot study of an experimental therapy for prostate cancer has found that a cancer vaccine can be safely administered to patients undergoing radiation therapy.
Timing is everything when it comes to killing prostate cancer cells with specially tailored vaccines. Most prostate cancer vaccines currently are tested on men whose cancers are growing and no longer responsive to hormone therapy.
The vast majority of men with prostate cancer will survive the disease and enjoy a high quality of life after treatment. Prostate cancer is the most common cancer in men.
A prostate cancer vaccine that trains a patient's own dendritic cells to attack a protein antigen expressed by tumors can robustly boost a patient's immune system.
Prostate screens could be 'teachable moment' to encourage colon checks. What men do pay attention to is prostate cancer. And that has researchers thinking an annual prostate cancer screening might be a good opportunity to urge men to be screened for colon cancer too.
Some Men with Low PSAs Have Prostate Cancer: Most Cancers Found Are Not Likely to Be Clinically Significant
Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer. In this study, prostate cancers were detected by biopsy in men with normal PSA levels.
Research indicates that prostate cancer is significantly lower in Asia than in North America. In fact, less than two percent of Asian men are diagnosed with prostate cancer.
Risk factors for developing prostate cancer include being 65 years of age or older, and a family history of the disease. Symptoms of prostate cancer include the following.
A promising new prostate cancer treatment not only provides quality of life benefits, but also offers a survival advantage for men whose cancer has metastasized, or spread to other parts of the body.
It is important to take care of your prostate and address any prostate, be it an enlarged prostate, prostetitis (inflammation of the prostate) or prostate cancer early on. Take an active role and protect yourself by having your prostate checked regularly.
Prostate ultrasound and biopsy is performed to evaluate abnormal results of a digital rectal exam or an elevated prostate-specific antigen (PSA). Prostate ultrasound is a procedure in which a probe about the size of a finger is inserted a short distance into the rectum.\n
Combination of Cancer Drugs Increases Survival Rate of Some Prostate Cancer Patients: New Research Shows
Prostate cancer patients whose cancer has spread to other parts of the body and who no longer respond to hormone therapy may benefit from a combination of the cancer drugs docetaxel and estramustine, according to a new study published in the Oct. 8 issue of the New England Journal of Medicine.
Having a close relative with prostate cancer is considered a risk factor for developing it yourself. In fact, hereditary prostate cancer accounts for 10 to 15 per cent of all cases and tends to develop at a relatively early age (before the age of 55). An individual who has two first-degree relatives (father and brother) with prostate cancer may be up to eight times more at risk of developing prostate cancer in his lifetime than a man with no family history.
Prostate cancer is the number one cancer threat to the lives and health of men. It is the most common cancer, and the second most deadly after lung cancer. An increasing number of men are expected to develop the disease in their lifetime, with 19,000 being diagnosed every year.
The prostate is a doughnut-shaped cluster of glands located at the bottom of the bladder about halfway between the rectum and the base of the penis. It encircles the urethra, the tube that carries urine from the bladder out through the penis.
TUNA and TUMT use heat to destroy part of the enlarged prostate to improve urine flow and symptoms. Early studies suggest that these procedures reduce the occurrence of erection or bladder control side effects, which occur more often with the traditional surgery for BPH, known as transurethral resection of the prostate (TURP).
Combined Drug Therapy Prevents Progression of Prostate Enlargement Helps Men at High Risk Avoid Surgery
A combination of drugs is significantly more effective than either drug alone for preventing progression of benign prostatic hyperplasia (BPH), especially in men at high risk for disease progression.
How can risk be determined? Although there is no specific cause related to the development of prostate cancer, there are certain factors that may increase a man's risk, including:
Prostatitis may account for up to 25 percent of all office visits by young and middle-aged men for complaints involving the genital and urinary systems. The term prostatitis actually encompasses four disorders.